Paar, V.,
Jirak, P.,
Larbig, R.,
Zagidullin, N.S.,
Brandt, M.C.,
Lichtenauer, M.,
Hoppe, U.C.,
Motloch, L.J. (2019) . We highlight the therapeutic potential of
gene therapy as a novel and innovative approach for future
WANG, K.,
LIU, H.,
LIU, J.,
WANG, X.,
TENG, L.,
ZHANG, J.,
CHEN, X.,
WANG, N.,
ZHONG, Y.,
HOU, X.,
JIANG, H.,
ZHANG, X.,
ZHAO, S.,
LIU, Y.,
YAO, Y.,
WANG, J.,
QU, Y.,
PENG, F.,
BEYLERLI, O.,
LIAO, X. (2019) that targeting amino acid metabolism such as methionine deprivation/IL1RN related
gene therapy may offer novel
FEDOROVA, Y.Y.,
KARUNAS, A.S.,
GIMALOVA, G.F.,
KHUSNUTDINOVA, E.K.,
SAVELIEVA, O.N,
MURZINA, R.R.,
GATIYATULLIN, R.F.,
ETKINA, E.I. (2019) –60% of differences in sensitivity to
therapy in patients with BA is due to genetic variability. We studied
and the key role of transposons in the regulation of
gene expression during ontogenesis. The silencing
LIU, Z.,
ZHANG, R.,
CHEN, X.,
YAO, P.,
YAN, T.,
LIU, W.,
YAO, J.,
ZHAO, S.,
SOKHATSKII, A.,
GAREEV, I. (2019) of intracerebral hemorrhage (ICH). We aimed to identify the hub
genes associated with intracerebral hemorrhage
revealed that some SNPs in chemokine
genes are associated with obesity, insulin resistance, type 2 diabetes